(Q33411837)

26 July 2017

title

The effect of moxifloxacin on QTc and implications for the design of thorough QT studies (English)

1 reference

26 July 2017

1 reference

Bloomfield DM

1

1 reference

26 July 2017

Kost JT

2

1 reference

26 July 2017

Ghosh K

3

1 reference

26 July 2017

Hreniuk D

4

1 reference

26 July 2017

Hickey LA

5

1 reference

26 July 2017

Guitierrez MJ

6

1 reference

26 July 2017

Gottesdiener K

7

1 reference

26 July 2017

Wagner JA

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Clinical Pharmacology & Therapeutics

26 July 2017

published in

1 reference

26 July 2017

volume

84

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

475-480

1 reference

Drug-induced prolongation of the QT interval

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Drug-induced torsades de pointes and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Effects of cisapride on QT interval in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

"Optimum" formulae for heart rate correction of the QT interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Autonomic nervous system influences on QT interval in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Autonomic modulation of the u wave during sympathomimetic stimulation and vagal inhibition in normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Comparison of automatic QT measurement techniques in the normal 12 lead electrocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Evaluation of vardenafil and sildenafil on cardiac repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Clinical assessment of drug-induced QT prolongation in association with heart rate changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Cardiotoxic effect with convulsions in terfenadine overdose

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Influence of heart rate and inhibition of autonomic tone on the QT interval

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Influence of the autonomic nervous system on the Q-T interval in man

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Sympathomimetic infusion and cardiac repolarization: the normative effects of epinephrine and isoproterenol in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Is there a physiologic QT/RR relationship?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.33

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.33

1 reference

26 July 2017

1 reference